High SARS-CoV-2 seroprevalence but no severe course of COVID-19 disease among people on opioid agonist treatment in Zurich: a cross-sectional study. (2022). Swiss Medical Weekly, 152(0102), w30122. https://doi.org/10.4414/SMW.2022.w30122